Oncology Corporate Profile
OncoRx Pharmaceuticals is a pharmaceutical company dedicated to the discovery and development of novel drugs that control tumor metastasis; disrupt proliferation; disrupt sustained directional migration; and downregulate distant tissue invasion of drug-resistant tumor cells.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|ORX 102||immunotherapy||Glioblastoma Multiforme (GBM)||Preclinical|
|ORX-101||immunotherapy||Glioblastoma Multiforme (GBM)||Preclinical|
View additional information on product candidates here »